ConductScience.org, home

Paper41041069

Hot-spot empowered gold nanoparticles for theranostics in breast cancer.

Tian M and 4 others. Theranostics, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Hot-spot empowered gold nanoparticles for theranostics in breast cancer. Papers, record 41041069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41041069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hot-spot empowered gold nanoparticles for theranostics in breast cancer.
PubMed
Journal
Theranostics
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-10-05
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian MMeng
2Hu SShiqi
3Sun WWen
4Hu YYing
5Ma XXingyi

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
GoldMajor topic
Theranostic NanomedicineMajor topic
Metal NanoparticlesMajor topic
Humans
Female
Photochemotherapy
Drug Delivery Systems
Animals
Photothermal Therapy

Source PubMed

Download CSV of topics

References144

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138062330A review on selenium and gold nanoparticles combined photodynamic and photothermal prostate cancer tumors ablation.Discov Nano2023https://conductscience.org/library/papers/38062330PubMed
239017700Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection.Anal Bioanal Chem2024https://conductscience.org/library/papers/39017700PubMed
339152194Innovation and challenges of artificial intelligence technology in personalized healthcare.Sci Rep2024https://conductscience.org/library/papers/39152194PubMed
437534056Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.Int J Nanomedicine2023https://conductscience.org/library/papers/37534056PubMed
536931265Deciphering breast cancer: from biology to the clinic.Cell2023https://conductscience.org/library/papers/36931265PubMed
630460281Microfluidics: Rapid Diagnosis for Breast Cancer.Nanomicro Lett2016https://conductscience.org/library/papers/30460281PubMed
732735811Polymer nanomedicines.Adv Drug Deliv Rev2020https://conductscience.org/library/papers/32735811PubMed
829774071Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device.Theranostics2018https://conductscience.org/library/papers/29774071PubMed
932036302Advances in nanomaterials for photodynamic therapy applications: Status and challenges.Biomaterials2020https://conductscience.org/library/papers/32036302PubMed
1031566198Synthesis of tunable DNA-directed trepang-like Au nanocrystals for imaging application.Nanoscale2019https://conductscience.org/library/papers/31566198PubMed
1139040452Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer.Front Oncol2024https://conductscience.org/library/papers/39040452PubMed
1233533597DNA-Mediated Au-Au Dimer-Based Surface Plasmon Coupling Electrochemiluminescence Sensor for BRCA1 Gene Detection.Anal Chem2021https://conductscience.org/library/papers/33533597PubMed
1331006932Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles.Angew Chem Int Ed Engl2019https://conductscience.org/library/papers/31006932PubMed
1434727233Cancer nanotechnology: current status and perspectives.Nano Converg2021https://conductscience.org/library/papers/34727233PubMed
1533524960Exploiting gold nanoparticles for diagnosis and cancer treatments.Nanotechnology2021https://conductscience.org/library/papers/33524960PubMed
1635890217Stimuli-Responsive Gold Nanocages for Cancer Diagnosis and Treatment.Pharmaceutics2022https://conductscience.org/library/papers/35890217PubMed
1722591323Chiral nanocrystals: plasmonic spectra and circular dichroism.Nano Lett2012https://conductscience.org/library/papers/22591323PubMed
1821723891Inorganic nanoparticles for cancer imaging and therapy.J Control Release2011https://conductscience.org/library/papers/21723891PubMed
1931472191Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy.J Control Release2019https://conductscience.org/library/papers/31472191PubMed
2035319200Ultrasensitive SERS Analysis of Liquid and Gaseous Putrescine and Cadaverine by a 3D-Rosettelike Nanostructure-Decorated Flexible Porous Substrate.Anal Chem2022https://conductscience.org/library/papers/35319200PubMed

See all 144 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41041069

GET https://conductscience.org/api/papers/v1/41041069/references?page=2